Merck opens new €290m U.S. biosafety testing facility
Merck has unveiled a large new biosafety testing facility in Rockville to meet the global demand.
Archives for October 15, 2024
FDA approves Pfizer's antibody treatment for hemophilia
The approval of Hympavzi makes it the first treatment for both hemophilia A and B to be administered through a pre-filled pen or syringe.